Cargando…
Efficacy and safety outcomes of early versus late cryoballoon ablation of atrial fibrillation - 24-months-results from the Cryo Global Registry
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): Medtronic, Inc., Minneapolis, MN, USA INTRODUCTION: Increasing evidence suggests early rhythm-control therapy in atrial fibrillation (AF) results in higher freedom from atrial arrhythmia (AA) recurrence and i...
Autores principales: | Lawin, D, Stellbrink, C, Chun, K R J, Li, C H, Kueffer, F, Selma, J, Oh, I Y, Herzet, J, Nitta, J, Chang, T Y, Lawrenz, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207395/ http://dx.doi.org/10.1093/europace/euad122.682 |
Ejemplares similares
-
Pulsed-field- vs. cryo- vs. radiofrequency ablation: one-year recurrence rates after pulmonary vein isolation in patients with persistent atrial fibrillation
por: Kueffer, T, et al.
Publicado: (2023) -
The outcomes of cryoballoon, high-power short-duration, and conventional radiofrequency atrial fibrillation catheter ablation: a propensity score weighted study
por: Park, H, et al.
Publicado: (2023) -
Pulsed field versus cryoballoon ablation of atrial fibrillation: A comparison of efficacy and safety in a 400 patient cohort
por: Urbanek, L, et al.
Publicado: (2023) -
Cryoballoon ablation for atrial fibrillation in octogenarians: a propensity-score matching comparison with a cohort of younger patients
por: Cecchini, F, et al.
Publicado: (2023) -
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective
por: Andrade, J, et al.
Publicado: (2023)